Tapewire

Nasdaq · USD

AVAH

Aveanna Healthcare Holdings, Inc.

Export transactions ↓
Tapewire entity
4246
SEC CIK
0001832332
Parsed reports
203

Last 12 months

Inside the activity.

0 purchase rows · 71 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 2025010
Jan 202605
Feb 2026015
Mar 202600
Apr 202600
May 202601
Jun 2026021
Jul 202600
Aug 2026019
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 14, 2023 Filed Feb 17, 2023 01:00 UTC GrantRestricted Stock Units · Derivative 103,175 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005308 · doc4.xml · derivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,175

Underlying: Common Stock, par value $0.01 per share · 103,175 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") provides for the right to receive one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: The RSUs vest on February 14, 2024. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

F2 · derivative.expiration_date: The RSUs vest on February 14, 2024. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 20:00 UTC GrantRestricted Stock Units · Derivative 103,175 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005309 · doc4.xml · derivative · entry 1

RODGERS STEVEN E · CIK 0001239604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,175

Underlying: Common Stock, par value $0.01 per share · 103,175 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") provides for the right to receive one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: The RSUs vest on February 14, 2024. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

F2 · derivative.expiration_date: The RSUs vest on February 14, 2024. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 20:00 UTC GrantRestricted Stock Units · Derivative 103,175 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005310 · doc4.xml · derivative · entry 1

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,175

Underlying: Common Stock, par value $0.01 per share · 103,175 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") provides for the right to receive one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: The RSUs vest on February 14, 2024. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

F2 · derivative.expiration_date: The RSUs vest on February 14, 2024. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

Read SEC document
February 14, 2023 Filed Feb 17, 2023 01:01 UTC GrantCommon Stock, par value $0.01 per share 119,048 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005313 · doc4.xml · nonDerivative · entry 1

Windley Rodney D · CIK 0001354351 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,897,437

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

F2 · balance_after: In connection with that certain separation agreement by and between Aveanna Healthcare Holdings Inc, a Delaware corporation (the "Company"), and the reporting person, setting forth, among other things, the terms of the reporting person's retirement as Executive Chairman of the Company effective December 31, 2022, the reporting person forfeited 134,254 restricted stock units previously reported on the Form 4 filed with the Securities and Exchange Commission on August 5, 2022.

Read SEC document
February 14, 2023 Filed Feb 17, 2023 01:55 UTC
Shaner JeffChief Executive Officer
GrantCommon Stock, par value $0.01 per share 421,094 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005329 · doc4.xml · nonDerivative · entry 1

Shaner Jeff · CIK 0001520693 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,648,719

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

F2 · balance_after: Includes (i) 739 shares acquired under Aveanna's Employee Stock Purchase Plan (the "ESPP") on January 4, 2022, (ii) 2,645 shares acquired under the ESPP on July 8, 2022, and (iii) 2,289 shares acquired under the ESPP on January 5, 2023.

Read SEC document
February 14, 2023 Filed Feb 17, 2023 01:57 UTC
Rubio BethChief Nursing Officer
GrantCommon Stock, par value $0.01 per share 70,313 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005333 · doc4.xml · nonDerivative · entry 1

Rubio Beth · CIK 0001858838 · Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,893

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

F2 · balance_after: Includes (i) 369 shares acquired under Aveanna's Employee Stock Purchase Plan (the "ESPP") on January 4, 2022, (ii) 1,439 shares acquired under the ESPP on July 8, 2022, and (iii) 4,874 shares acquired under the ESPP on January 5, 2023.

Read SEC document
February 14, 2023 Filed Feb 17, 2023 01:57 UTC
Cunningham Patrick A.Chief Compliance Officer
GrantCommon Stock, par value $0.01 per share 58,594 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005332 · doc4.xml · nonDerivative · entry 1

Cunningham Patrick A. · CIK 0001858847 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,465

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

F2 · balance_after: Includes (i) 504 shares acquired under Aveanna's Employee Stock Purchase Plan (the "ESPP") on January 4, 2022, (ii) 3,004 shares acquired under the ESPP on July 8, 2022, and (iii) 1,168 shares acquired under the ESPP on January 5, 2023.

Read SEC document
February 14, 2023 Filed Feb 17, 2023 01:55 UTC
Reisz Edwin C.Chief Administrative Officer
GrantCommon Stock, par value $0.01 per share 187,500 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005330 · doc4.xml · nonDerivative · entry 1

Reisz Edwin C. · CIK 0001859462 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,080,206

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

F2 · balance_after: Includes (i) 252 shares acquired under Aveanna's Employee Stock Purchase Plan (the "ESPP") on January 4, 2022, (ii) 914 shares acquired under the ESPP on July 8, 2022, and (iii) 3,250 shares acquired under the ESPP on January 5, 2023.

Read SEC document
February 14, 2023 Filed Feb 17, 2023 01:53 UTC
Afshar DavidChief Financial Officer
GrantCommon Stock, par value $0.01 per share 314,688 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005325 · doc4.xml · nonDerivative · entry 1

Afshar David · CIK 0001858855 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 602,928

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

Read SEC document
February 14, 2023 Filed Feb 17, 2023 01:54 UTC
Drake ShannonSee Remarks
GrantCommon Stock, par value $0.01 per share 187,500 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005327 · doc4.xml · nonDerivative · entry 1

Drake Shannon · CIK 0001858841 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 398,977

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

Read SEC document
August 24, 2022 Filed Aug 25, 2022 00:56 UTC
Afshar DavidChief Financial Officer
PurchaseCommon Stock, par value $0.01 per share 10,000 $2.01 $20,140.00
Disclosure

SEC source: 0000899243-22-029693 · doc4.xml · nonDerivative · entry 1

Afshar David · CIK 0001858855 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,240

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.99 to $2.03, inclusive. The reporting person undertakes to provide to Aveanna Healthcare Holdings Inc. ("Aveanna"), any security holder of Aveanna, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · balance_after: Includes 2,482 shares acquired under Aveanna's Employee Stock Purchase Plan on January 4, 2022, and 3,378 shares acquired under Aveanna's Employee Stock Purchase Plan on July 8, 2022.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 22:00 UTC GrantRestricted Stock Units · Derivative 61,611 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-029054 · doc4.xml · derivative · entry 1

Schwartz Erica · CIK 0001872122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,611

Underlying: Common Stock, par value $0.01 per share · 61,611 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

F2 · derivative.expiration_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 18:00 UTC GrantRestricted Stock Units · Derivative 61,611 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-029053 · doc4.xml · derivative · entry 1

Retchin Sheldon M · CIK 0001470958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,611

Underlying: Common Stock, par value $0.01 per share · 61,611 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

F2 · derivative.expiration_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 22:00 UTC GrantRestricted Stock Units · Derivative 61,611 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-029049 · doc4.xml · derivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,611

Underlying: Common Stock, par value $0.01 per share · 61,611 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

F2 · derivative.expiration_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 18:00 UTC GrantRestricted Stock Units · Derivative 61,611 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-029052 · doc4.xml · derivative · entry 1

RODGERS STEVEN E · CIK 0001239604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,611

Underlying: Common Stock, par value $0.01 per share · 61,611 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

F2 · derivative.expiration_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 18:00 UTC GrantRestricted Stock Units · Derivative 61,611 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-029050 · doc4.xml · derivative · entry 1

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,611

Underlying: Common Stock, par value $0.01 per share · 61,611 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

F2 · derivative.expiration_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date.

Read SEC document
June 30, 2022 Filed Jul 6, 2022 01:00 UTC Exercise / conversionRestricted Stock Units · Derivative 10,509 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-025154 · doc4.xml · derivative · entry 2

Schwartz Erica · CIK 0001872122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.01 per share · 10,509 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022.

F2 · derivative.expiration_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022.

Read SEC document
June 30, 2022 Filed Jul 6, 2022 01:00 UTC Exercise / conversionCommon Stock 10,509 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-025154 · doc4.xml · nonDerivative · entry 1

Schwartz Erica · CIK 0001872122 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 21:00 UTC Exercise / conversionRestricted Stock Units · Derivative 10,509 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-025155 · doc4.xml · derivative · entry 2

Retchin Sheldon M · CIK 0001470958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.01 per share · 10,509 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022.

F2 · derivative.expiration_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 21:00 UTC Exercise / conversionCommon Stock 10,509 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-025155 · doc4.xml · nonDerivative · entry 1

Retchin Sheldon M · CIK 0001470958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,757

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

Read SEC document
June 30, 2022 Filed Jul 6, 2022 01:00 UTC Exercise / conversionRestricted Stock Units · Derivative 10,509 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-025156 · doc4.xml · derivative · entry 2

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.01 per share · 10,509 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022.

F2 · derivative.expiration_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022.

Read SEC document
June 30, 2022 Filed Jul 6, 2022 01:00 UTC Exercise / conversionCommon Stock 10,509 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-025156 · doc4.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,009

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 21:00 UTC Exercise / conversionRestricted Stock Units · Derivative 10,509 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-025152 · doc4.xml · derivative · entry 2

RODGERS STEVEN E · CIK 0001239604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.01 per share · 10,509 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022.

F2 · derivative.expiration_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 21:00 UTC Exercise / conversionCommon Stock 10,509 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-025152 · doc4.xml · nonDerivative · entry 1

RODGERS STEVEN E · CIK 0001239604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 21:00 UTC Exercise / conversionRestricted Stock Units · Derivative 10,509 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-025153 · doc4.xml · derivative · entry 2

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.01 per share · 10,509 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

F2 · derivative.exercise_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022.

F2 · derivative.expiration_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 21:00 UTC Exercise / conversionCommon Stock 10,509 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-025153 · doc4.xml · nonDerivative · entry 1

GANZI VICTOR F · CIK 0001199070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,609

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc.

Read SEC document
May 26, 2022 Filed May 31, 2022 20:30 UTC
Cunningham Patrick A.Chief Compliance Officer
PurchaseCommon Stock, par value $0.01 per share 3,100 $3.11 $9,625.50
Disclosure

SEC source: 0000899243-22-020178 · doc4.xml · nonDerivative · entry 1

Cunningham Patrick A. · CIK 0001858847 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,195

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.090 to $3.140, inclusive. The reporting person undertakes to provide to Aveanna Healthcare Holdings Inc. ("Aveanna"), any security holder of Aveanna, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 20, 2022 Filed May 24, 2022 20:30 UTC
Reisz Edwin C.Chief Administrative Officer
PurchaseCommon Stock, par value $0.01 per share 9,000 $2.88 $25,929.00
Disclosure

SEC source: 0000899243-22-019366 · doc4.xml · nonDerivative · entry 1

Reisz Edwin C. · CIK 0001859462 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 888,290

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.85 to $2.90, inclusive. The reporting person undertakes to provide to Aveanna Healthcare Holdings Inc. ("Aveanna"), any security holder of Aveanna, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 19, 2022 Filed May 20, 2022 17:32 UTC
Strange TonyDirector · See Remarks
PurchaseCommon Stock, par value $0.01 per share 36,000 $2.90 $104,544.00
Disclosure

SEC source: 0000899243-22-019087 · doc4.xml · nonDerivative · entry 1

Strange Tony · CIK 0001354350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680,134

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.85 to $2.97, inclusive. The reporting person undertakes to provide to Aveanna Healthcare Holdings Inc. ("Aveanna"), any security holder of Aveanna, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 19, 2022 Filed May 20, 2022 21:24 UTC
Windley Rodney DDirector · Director, Executive Chairman
PurchaseCommon Stock, par value $0.01 per share 36,000 $2.91 $104,580.00
Disclosure

SEC source: 0000899243-22-019081 · doc4.xml · nonDerivative · entry 1

Windley Rodney D · CIK 0001354351 · Director · Director, Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680,134

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.85 to $2.97, inclusive. The reporting person undertakes to provide to Aveanna Healthcare Holdings Inc. ("Aveanna"), any security holder of Aveanna, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 19, 2022 Filed May 20, 2022 21:26 UTC
Shaner JeffChief Operating Officer
PurchaseCommon Stock, par value $0.01 per share 9,000 $2.91 $26,145.00
Disclosure

SEC source: 0000899243-22-019083 · doc4.xml · nonDerivative · entry 1

Shaner Jeff · CIK 0001520693 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,221,952

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.82 to $2.97, inclusive. The reporting person undertakes to provide to Aveanna Healthcare Holdings Inc. ("Aveanna"), any security holder of Aveanna, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 18, 2022 Filed May 19, 2022 17:10 UTC PurchaseCommon Stock, par value $0.01 per share 6,000 $2.70 $16,182.00
Disclosure

SEC source: 0000899243-22-018868 · doc4.xml · nonDerivative · entry 2

RODGERS STEVEN E · CIK 0001239604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,000

Read SEC document
May 17, 2022 Filed May 19, 2022 17:10 UTC PurchaseCommon Stock, par value $0.01 per share 30,000 $2.84 $85,260.00
Disclosure

SEC source: 0000899243-22-018868 · doc4.xml · nonDerivative · entry 1

RODGERS STEVEN E · CIK 0001239604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.826 to $2.854, inclusive. The reporting person undertakes to provide to Aveanna Healthcare Holdings Inc. ("Aveanna"), any security holder of Aveanna, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 16, 2022 Filed May 17, 2022 22:56 UTC
Afshar DavidChief Financial Officer
PurchaseCommon Stock, par value $0.01 per share 12,036 $2.86 $34,407.31
Disclosure

SEC source: 0000899243-22-018455 · doc4.xml · nonDerivative · entry 1

Afshar David · CIK 0001858855 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,380

Read SEC document
February 14, 2022 Filed Feb 17, 2022 02:30 UTC
Shaner JeffChief Operating Officer
GrantCommon Stock, par value $0.01 per share 136,663 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006707 · doc4.xml · nonDerivative · entry 1

Shaner Jeff · CIK 0001520693 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,212,952

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

Read SEC document
February 14, 2022 Filed Feb 17, 2022 02:31 UTC
Reisz Edwin C.Chief Administrative Officer
GrantCommon Stock, par value $0.01 per share 50,304 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006708 · doc4.xml · nonDerivative · entry 1

Reisz Edwin C. · CIK 0001859462 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 879,290

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

Read SEC document
February 14, 2022 Filed Feb 17, 2022 02:30 UTC
Rubio BethChief Clinical Officer
GrantCommon Stock, par value $0.01 per share 22,819 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006706 · doc4.xml · nonDerivative · entry 1

Rubio Beth · CIK 0001858838 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,898

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

Read SEC document
February 14, 2022 Filed Feb 17, 2022 02:30 UTC
Afshar DavidChief Financial Officer
GrantCommon Stock, par value $0.01 per share 102,130 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006704 · doc4.xml · nonDerivative · entry 1

Afshar David · CIK 0001858855 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,344

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

Read SEC document
February 14, 2022 Filed Feb 17, 2022 02:30 UTC
Cunningham Patrick A.Chief Compliance Officer
GrantCommon Stock, par value $0.01 per share 19,016 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006705 · doc4.xml · nonDerivative · entry 1

Cunningham Patrick A. · CIK 0001858847 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,095

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

Read SEC document
February 14, 2022 Filed Feb 17, 2022 02:30 UTC
Drake ShannonSee Remarks
GrantCommon Stock, par value $0.01 per share 60,852 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006703 · doc4.xml · nonDerivative · entry 1

Drake Shannon · CIK 0001858841 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,477

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

Read SEC document
February 14, 2022 Filed Aug 5, 2022 17:00 UTC
Strange TonyDirector · See Remarks
GrantCommon Stock, par value $0.01 per share 268,509 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-027843 · doc4.xml · nonDerivative · entry 1

Strange Tony · CIK 0001354350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,915,125

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

F2 · balance_after: Includes 2,482 shares acquired under the issuer's Employee Stock Purchase Plan on January 4, 2022.

Read SEC document
February 14, 2022 Filed Aug 5, 2022 21:00 UTC
Windley Rodney DDirector · Director, Executive Chairman
GrantCommon Stock, par value $0.01 per share 268,509 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-027845 · doc4.xml · nonDerivative · entry 1

Windley Rodney D · CIK 0001354351 · Director · Director, Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,912,643

F1 · price: Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

Read SEC document
December 29, 2021 Filed Jan 3, 2022 21:16 UTC
Shaner JeffChief Operating Officer
GrantCommon Stock, par value $0.01 per share 180,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-000131 · doc4.xml · nonDerivative · entry 1

Shaner Jeff · CIK 0001520693 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,076,289

F1 · price: Grant of stock-settled restricted stock unit, subject to four-year cliff vesting.

Read SEC document
December 29, 2021 Filed Jan 3, 2022 21:15 UTC
Drake ShannonSee Remarks
GrantCommon Stock, par value $0.01 per share 125,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-000133 · doc4.xml · nonDerivative · entry 1

Drake Shannon · CIK 0001858841 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,625

F1 · price: Grant of stock-settled restricted stock unit, subject to four-year cliff vesting.

Read SEC document
December 29, 2021 Filed Jan 3, 2022 21:15 UTC
Rubio BethChief Clinical Officer
GrantCommon Stock, par value $0.01 per share 75,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-000128 · doc4.xml · nonDerivative · entry 1

Rubio Beth · CIK 0001858838 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,079

F1 · price: Grant of stock-settled restricted stock unit, subject to four-year cliff vesting.

Read SEC document
December 29, 2021 Filed Jan 3, 2022 21:15 UTC
Cunningham Patrick A.Chief Compliance Officer
GrantCommon Stock, par value $0.01 per share 75,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-000127 · doc4.xml · nonDerivative · entry 1

Cunningham Patrick A. · CIK 0001858847 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,079

F1 · price: Grant of stock-settled restricted stock unit, subject to four-year cliff vesting.

Read SEC document
December 29, 2021 Filed Jan 3, 2022 21:15 UTC
Reisz Edwin C.Chief Administrative Officer
GrantCommon Stock, par value $0.01 per share 125,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-000125 · doc4.xml · nonDerivative · entry 1

Reisz Edwin C. · CIK 0001859462 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 828,986

F1 · price: Grant of stock-settled restricted stock unit, subject to four-year cliff vesting.

Read SEC document
December 29, 2021 Filed Jan 3, 2022 21:15 UTC
Afshar DavidChief Financial Officer
GrantCommon Stock, par value $0.01 per share 130,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-000124 · doc4.xml · nonDerivative · entry 1

Afshar David · CIK 0001858855 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,214

F1 · price: Grant of stock-settled restricted stock unit, subject to four-year cliff vesting.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 17:56 UTC
Strange TonyDirector · See Remarks
PurchaseCommon Stock, par value $0.01 per share 15,000 $6.48 $97,200.00
Disclosure

SEC source: 0000899243-21-048831 · doc4.xml · nonDerivative · entry 1

Strange Tony · CIK 0001354350 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,644,134

Read SEC document
December 15, 2021 Filed Dec 17, 2021 22:52 UTC
Windley Rodney DDirector · Director, Executive Chairman
PurchaseCommon Stock, par value $0.01 per share 15,000 $6.51 $97,650.00
Disclosure

SEC source: 0000899243-21-048829 · doc4.xml · nonDerivative · entry 1

Windley Rodney D · CIK 0001354351 · Director · Director, Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,644,134

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.